Big Data Offers Novel Insights for Oncolytic Virus Immunotherapy

Por Swift, Stephanie L., Stojdl, David F.
Publicado no Viruses (2016)

High-throughput screening to enhance oncolytic virus immunotherapy

Por Allan, KJ, Stojdl, David F, Swift, SL
Publicado no Oncolytic Virother (2016)

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Por Allan, Kristina J., Mahoney, Douglas J., Baird, Stephen D., Lefebvre, Charles A., Stojdl, David F.
Publicado no J Vis Exp (2018)

Characterizing Cellular Responses During Oncolytic Maraba Virus Infection

Por Hassanzadeh, Golnoush, Naing, Thet, Graber, Tyson, Jafarnejad, Seyed Mehdi, Stojdl, David F., Alain, Tommy, Holcik, Martin
Publicado no Int J Mol Sci (2019)

Activating Peripheral Innate Immunity Enables Safe and Effective Oncolytic Virotherapy in the Brain

Por Balathasan, Lukxmi, Tang, Vera A., Yadollahi, Beta, Brun, Jan, Labelle, Melanie, Lefebvre, Charles, Swift, Stephanie L., Stojdl, David F.
Publicado no Mol Ther Oncolytics (2017)

The Murine Double-Stranded RNA-Dependent Protein Kinase PKR Is Required for Resistance to Vesicular Stomatitis Virus

Por Stojdl, David F., Abraham, Ninan, Knowles, Shane, Marius, Ricardo, Brasey, Ann, Lichty, Brian D., Brown, Earl G., Sonenberg, Nahum, Bell, John C.
Publicado em 2000

Triptolide-Mediated Inhibition of Interferon Signaling Enhances Vesicular Stomatitis Virus-Based Oncolysis

Por Ben Yebdri, Fethia, Van Grevenynghe, Julien, Tang, Vera A, Goulet, Marie-Line, Wu, Jian Hui, Stojdl, David F, Hiscott, John, Lin, Rongtuan
Publicado em 2013

Identification of Genetically Modified Maraba Virus as an Oncolytic Rhabdovirus

Por Brun, Jan, McManus, Dan, Lefebvre, Charles, Hu, Kang, Falls, Theresa, Atkins, Harold, Bell, John C, McCart, J. Andrea, Mahoney, Douglas, Stojdl, David F
Publicado em 2010

Maraba Virus as a Potent Oncolytic Vaccine Vector

Por Pol, Jonathan G, Zhang, Liang, Bridle, Byram W, Stephenson, Kyle B, Rességuier, Julien, Hanson, Stephen, Chen, Lan, Kazdhan, Natasha, Bramson, Jonathan L, Stojdl, David F, Wan, Yonghong, Lichty, Brian D
Publicado em 2014

Oncolytic virus synergizes with Smac mimetic compounds to induce rhabdomyosarcoma cell death in a syngeneic murine model

Por Dobson, Christine C, Naing, Thet, Beug, Shawn T, Faye, Mame D, Chabot, Janelle, St-Jean, Martin, Walker, Danielle E, LaCasse, Eric C, Stojdl, David F, Korneluk, Robert G, Holcik, Martin
Publicado no Oncotarget (2016)

Development and applications of oncolytic Maraba virus vaccines

Por Pol, Jonathan G, Atherton, Matthew J, Bridle, Byram W, Stephenson, Kyle B, Le Boeuf, Fabrice, Hummel, Jeff L, Martin, Chantal G, Pomoransky, Julia, Breitbach, Caroline J, Diallo, Jean-Simon, Stojdl, David F, Bell, John C, Wan, Yonghong, Lichty, Brian D
Publicado no Oncolytic Virother (2018)

Chemical targeting of the innate antiviral response by histone deacetylase inhibitors renders refractory cancers sensitive to viral oncolysis

Por Nguyên, Thi Lien-Anh, Abdelbary, Hesham, Arguello, Meztli, Breitbach, Caroline, Leveille, Simon, Diallo, Jean-Simon, Yasmeen, Amber, Bismar, Tarek A., Kirn, David, Falls, Theresa, Snoulten, Valerie E., Vanderhyden, Barbara C., Werier, Joel, Atkins, Harold, Vähä-Koskela, Markus J. V., Stojdl, David F., Bell, John C., Hiscott, John
Publicado em 2008

Maraba MG1 Virus Enhances Natural Killer Cell Function via Conventional Dendritic Cells to Reduce Postoperative Metastatic Disease

Por Zhang, Jiqing, Tai, Lee-Hwa, Ilkow, Carolina S, Alkayyal, Almohanad A, Ananth, Abhirami A, de Souza, Christiano Tanese, Wang, Jiahu, Sahi, Shalini, Ly, Lundi, Lefebvre, Charles, Falls, Theresa J, Stephenson, Kyle B, Mahmoud, Ahmad B, Makrigiannis, Andrew P, Lichty, Brian D, Bell, John C, Stojdl, David F, Auer, Rebecca C
Publicado em 2014

Complement inhibition enables tumor delivery of LCMV glycoprotein pseudotyped viruses in the presence of antiviral antibodies

Por Evgin, Laura, Ilkow, Carolina S, Bourgeois-Daigneault, Marie-Claude, de Souza, Christiano Tanese, Stubbert, Lawton, Huh, Michael S, Jennings, Victoria A, Marguerie, Monique, Acuna, Sergio A, Keller, Brian A, Lefebvre, Charles, Falls, Theresa, Le Boeuf, Fabrice, Auer, Rebecca A, Lambris, John D, McCart, J Andrea, Stojdl, David F, Bell, John C
Publicado no Mol Ther Oncolytics (2016)

Transforming the prostatic tumor microenvironment with oncolytic virotherapy

Por Atherton, Matthew J., Stephenson, Kyle B., Tzelepis, Fanny, Bakhshinyan, David, Nikota, Jake K., Son, Hwan Hee, Jirovec, Anna, Lefebvre, Charles, Dvorkin-Gheva, Anna, Ashkar, Ali A., Wan, Yonghong, Stojdl, David F., Belanger, Eric C., Breau, Rodney H., Bell, John C., Saad, Fred, Singh, Sheila K., Diallo, Jean-Simone, Lichty, Brian D.
Publicado no Oncoimmunology (2018)

Harnessing Oncolytic Virus-mediated Antitumor Immunity in an Infected Cell Vaccine

Por Lemay, Chantal G, Rintoul, Julia L, Kus, Agnieszka, Paterson, Jennifer M, Garcia, Vanessa, Falls, Theresa J, Ferreira, Lisa, Bridle, Byram W, Conrad, David P, Tang, Vera A, Diallo, Jean-Simon, Arulanandam, Rozanne, Le Boeuf, Fabrice, Garson, Kenneth, Vanderhyden, Barbara C, Stojdl, David F, Lichty, Brian D, Atkins, Harold L, Parato, Kelley A, Bell, John C, Auer, Rebecca C
Publicado em 2012

Preclinical evaluation of a MAGE-A3 vaccination utilizing the oncolytic Maraba virus currently in first-in-human trials

Por Pol, Jonathan G., Acuna, Sergio A., Yadollahi, Beta, Tang, Nan, Stephenson, Kyle B., Atherton, Matthew J., Hanwell, David, El-Warrak, Alexander, Goldstein, Alyssa, Moloo, Badru, Turner, Patricia V., Lopez, Roberto, LaFrance, Sandra, Evelegh, Carole, Denisova, Galina, Parsons, Robin, Millar, Jamie, Stoll, Gautier, Martin, Chantal G., Pomoransky, Julia, Breitbach, Caroline J., Bramson, Jonathan L., Bell, John C., Wan, Yonghong, Stojdl, David F., Lichty, Brian D., McCart, J. Andrea
Publicado no Oncoimmunology (2018)